Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Am J Obstet Gynecol. 2022 Feb 22;227(1):61.e1–61.e18. doi: 10.1016/j.ajog.2022.02.022

Table 5:

Comparison by ovarian volume

RRSO Control
Pre-RRSO Post-RRSO Baseline Follow-up P1 P2 P3
Quartile Ovarian Volume Quartile Ovarian Volume Quartile Ovarian Volume Quartile Ovarian Volume
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4
N 31 36 36 36 31 36 36 36 7 9 13 6 7 9 13 6
Testosterone 0.16 (0.14, 0.19) 0.21 (0.16, 0.26) 0.2 (0.16, 0.23) 0.21 (0.16, 0.26) 0.12 (0.1, 0.13) 0.22 (0.15, 0.3 0.15 (0.09, 0.21) 0.14 (0.11, 0.17) 0.16 (0.14, 0.19) 0.17 (0.11, 0.24) 0.22 (0.14, 0.3) 0.16 (0.1, 0.23) 0.19 (0.14, 0.23) 0.14 (0.11, 0.17) 0.17 (0.11, 0.24) 0.17 (0.12, 0.23) 0.41 <0.01 0.89
Androstenedione 0.51 (0.44, 0.57) 0.58 (0.46, 0.71) 0.54 (0.45, 0.63) 0.57 (0.46, 0.69) 0.4 (0.35, 0.47) 0.57 (0.47, 0.67) 0.48 (0.39, 0.57) 0.42 (0.34, 0.5) 0.46 (0.35, 0.59) 0.35 (0.31, 0.39) 0.62 (0.46, 0.79) 0.43 (0.28, 0.6) 0.55 (0.35, 0.79) 0.38 (0.3, 0.46) 0.46 (0.34, 0.6) 0.54 (0.26, 0.88) 0.60 <0.01 0.88
Androstenediol 253.7 (215.6, 298.4) 258.8 (210.5, 318.2) 224.9 (186.5, 271.1) 256.2 (201.7, 325.5) 227.1 (187.7, 274.9) 251.1 (199.6, 315.9) 187.7 (148.1, 237.7) 229.4 (172.1, 305.8) 234.1 (154.3, 355.0) 231.8 (183, 293.5) 269.4 (177.9, 407.8) 203.4 (132.7, 311.3) 243.7 (163.0, 364.1) 207.5 (136.3, 315.8) 197.3 (133.1, 292.4) 191.5 (131.1, 279.4) 0.57 <0.01 0.71
Dihydrotestosterone 28.1 (23.2, 33.9) 34.5 (28.7, 41.5) 31.1 (25.4, 38.1) 35.6 (28.0, 45.2) 25.3 (20.5, 31.3) 30.2 (24.6, 37.1) 26.7 (20.5, 34.6) 28.7 (22.2, 37.0) 35.2 (21.1, 58.5) 35.6 (26.1, 48.4) 31.1 (19.0, 50.6) 36.7 (18.7, 71.1) 36.3 (20.3, 64.6) 33.8 (23.1, 49.2) 25.3 (16.2, 39.2) 35.6 (21.3, 59.1) 0.13 0.11 0.68
Androsterone 111.2 (93.1, 132.8) 119.3 (102.2, 139.3) 106.8 (90.8, 125.5) 119.3 (95.9, 148.3) 108.9 (84.9, 139.7) 118.1 (98.2, 142.0) 94.6 (77.8, 114.9) 107.9 (88.1, 132) 104.6 (77.0, 142.1) 114.6 (97.2, 135.1) 114.6 (77.1, 170) 133.3 (81.4, 217.8) 107.9 (78.2, 148.7) 115.7 (88.3, 151.6) 94.6 (62.9, 141.9) 121.7 (74.9, 197.4) 0.51 0.08 0.42
Dehydroepiandrosterone 2.0 ( 1.7, 2.3) 2.2 1.7, 2.6) 2.0 (1.7, 2.5) 1.9 (1.6, 2.4) 1.7 (1.4, 2.1) 2.3 (1.8, 2.8) 1.9 (1.4, 2.3) 1.9 (1.5, 2.4) 1.8 (1.2, 2.7) 1.8 (1.4, 2.2) 2.3 (1.5, 3.4) 1.7 (1.0, 2.8) 1.9 (1.1, 2.8) 1.7 (1.2, 2.4) 1.7 (1.1, 2.4) 1.6 (1.0, 2.5) 0.89 <0.01 0.75
Estrone 15.9 (13.0, 19.6) 18.7 (15.6, 22.4) 17.4 (13.6, 22.1) 27.8 (20.4, 37.8) 14.3 (11.3, 18.1) 16.5 (13.4, 20.1) 19.9 (13.9, 28.3) 15.4 (11.9, 20.0) 16.3 (9.2, 28.3) 16.5 (12.3, 22.0) 21.4 (14.9, 30.6) 25.6 (16.5, 39.3) 16.1 (9.5, 26.9) 16.6 (12.4, 22.2) 16.8 (11.5, 24.4) 35.2 (17.7, 69.4) 0.28 <0.01 0.30
Estradiol 3.0 (2.2, 4.0) 4.2 (3.1, 5.6) 4.0 (2.8, 5.5) 14.8 (8.7, 24.6) 2.9 (2.0, 4.2) 3.2 (2.5, 4.1) 4.0 (2.7, 5.8) 3.1 (2.4, 4.1) 3.2 (1.8, 5.4) 4.5 (2.5, 7.5) 6.0 (3.5, 10.1) 8.4 (2.5, 24.5) 3.0 (1.7, 4.8) 3.5 (2.3, 5.2) 3.3 (2.3, 4.7) 12.9 (2.3, 56.6) 0.53 <0.01 0.02
SHBG 68.4 (54, 86.6) 69.1 (55.7, 85.7) 68.4 (54.0, 86.5) 63.7 (50.8, 79.8) 74.9 (59.4, 94.5) 70.5 (58.2, 85.4) 67.0 (53.3, 84.2) 57.0 (44.0, 73.8) 80.5 (43.0, 149.6) 80.5 (54.4, 118.8) 73.4 (52.4, 102.7) 81.3 (42, 156.3) 95.5 (54, 168.5) 74.9 (54.9, 102.2) 65.0 (49.9, 84.7) 97.5 (75.9, 125.2) <0.01 0.49 0.12

P1: Ovarian volume; P2: Pre vs. Post; P3: RSSO vs. Controls